Atlassian uses cookies to improve your browsing experience, perform analytics and research, and conduct advertising. Accept all cookies to indicate that you agree to our use of cookies on your device. Atlassian cookies and tracking notice, (opens new window)
Welcome to the PHUSE Advance Hub

WORKING GROUPS
Results will update as you type.
  • Working Groups
    • Data Transparency
      • Anonymization of Imaging Data
      • Educate the General Population on Data Privacy and Data Sharing
      • EU CTR Implementation
      • Internal Clinical Study Data Sharing Process
      • Patient Data Return
      • PHUSE Stakeholder Review of UK MHRA Clinical Trials Regulation Guidance
      • The Value of Plain Language Summaries of Trial Results
    • Data Visualisation & Open Source Technology
    • Emerging Trends & Innovation
    • Nonclinical Topics
    • Optimizing the Use of Data Standards
    • pharmaverse
    • Real World Evidence
    • Risk Based Quality Management
    • Safety Analytics
  • Hot Topics
  • Useful Information
  • Deliverables
  • Working Groups Events
  • Working Groups Report – Q3 2025
  • Working Groups Archive
  • Working Groups Events Archive

    You‘re viewing this with anonymous access, so some content might be blocked.
    /
    The Value of Plain Language Summaries of Trial Results

      The Value of Plain Language Summaries of Trial Results

      yesterday at 11:11 am

      Project Scope

      To generate evidence of the value of PLSs, a cross-industry/multi-stakeholder team will be formed to:

      • Develop a survey to evaluate the value of PLSs, to be placed on designated websites where PLSs are hosted
      • Collect data based on the survey and review any feedback
      • Report results in the form of a white paper.


      The team will meet regularly to define the team objective and work on the above deliverables.

      Problem Statement

      While the industry has put significant efforts into developing and disseminating plain language summaries of trial results (PLSs) to promote transparency and engagement, there remains a gap in quantitative evidence of how these documents are used and what value they bring to the trial participants and the general public. Gathering feedback from trial participants – the primary audience for PLSs – and other readers will provide meaningful insights into their value and inform improvements.

      Problem Impact

      This project aims to fill the gap and generate quantitative evidence about the use and value of PLSs. This will likely help sponsors use the evidence to support the need for writing and disseminating PLSs. This project may also help uncover areas that can be further improved for a better user experience.  

       
      Project LeadsEmail 
      Debra Guerreiro, Johnson & Johnsondguerre2@its.jnj.com
      Video Vashisht, Krystelisvidhi.vashisht@krystelis.com
      Lucy Marks, PHUSE Senior Project Coordinatorlucy@phuse.global

      CURRENT STATUS (Updated Quarterly) 

      • Project initiation and kick off meeting. 
      Objectives & DeliverablesTimelines
      • A team charter
      • Survey roll-out
      • Report the results as a white paper
      • Q3/4 2025
      • Q1 2026
      • Q3 2026
      , multiple selections available, Use left or right arrow keys to navigate selected items
      unrestored-unknown-attachment
      {"serverDuration": 37, "requestCorrelationId": "3d946d9c9a23443599a71bbf788586b7"}